IGC Pharma (IGC) Accumulated Expenses (2011 - 2026)
IGC Pharma (IGC) posted quarterly Accumulated Expenses of $495000.0 for Q1 2026, down 63.97% year-over-year from $1.4 million in Q1 2025, and down 48.54% quarter-over-quarter from $962000.0 in Q4 2025.
IGC Pharma (IGC) Accumulated Expenses (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Accumulated Expenses for 14 consecutive years, with $495000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses fell 63.97% year-over-year to $495000.0; the TTM figure through Mar 2026 stood at $495000.0 (down 63.97% YoY), while the FY2026 annual figure was $495000.0, down 63.97% from the prior year.
- Accumulated Expenses declined to $495000.0 in Q1 2026 per IGC's latest filing, from $962000.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $1.8 million in Q4 2024 and bottomed at $191000.0 in Q2 2025.
- Historically, Accumulated Expenses has averaged $978363.6 across 4 years, with a median of $1.0 million in 2024.
- Annual changes were most pronounced in 2024 — Accumulated Expenses jumped 153.15% — and 2025, when it tumbled 81.13%.
- IGC Pharma's Accumulated Expenses stood at $1.3 million in 2023, then jumped by 41.46% to $1.8 million in 2024, then plunged by 47.2% to $962000.0 in 2025, then slumped by 48.54% to $495000.0 in 2026.
- Business Quant data shows IGC's Accumulated Expenses at $495000.0 in Q1 2026, $962000.0 in Q4 2025, and $398000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | IGC Pharma | 30.17 Mn | 29.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 495,000.00 |
| Dec 31, 2025 | 962,000.00 |
| Sep 30, 2025 | 398,000.00 |
| Jun 30, 2025 | 191,000.00 |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Mar 31, 2023 | 619,000.00 |
| Dec 31, 2020 | 16,000.00 |
| Sep 30, 2020 | 16,000.00 |
| Mar 31, 2020 | 17,000.00 |
| Dec 31, 2019 | 652,000.00 |
| Sep 30, 2019 | 677,000.00 |
| Jun 30, 2019 | 452,000.00 |
| Mar 31, 2019 | 509,000.00 |
| Sep 30, 2018 | 204,000.00 |
| Jun 30, 2018 | 148,947.00 |